Experiment 667467

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

TRIPTOLIDE

Details

PropertyValue
Pharmacology
INTERLEUKIN-2 FORMATION INHIBITION
OrganismEmpty organism
CitationQIU,D: ZHAO,G: AOKI,Y: SHI,LF: UYEI,A: NAZARIAN,S: NG,JCH: KAO,PN:. (1999). IMMUNOSUPPRESSANT PG490 (TRIPTOLIDE) INHIBITS T-CELL INTERLEYUKIN-2 EXPRESSION AT THE LEVEL OF PURINE-BOX/NUCLEAR FACTOR OF ACTIVATED T-CELLS AND NF-KALPHA TRANSCRIPTIONAL ACTIVATION.. 274(19)
Amount utilized
Compound isolated
DiseaseVS.PMA/INO STIMULATION.
Dose amount40.0M NG
Number2
Qualitative resultACTIVE
AnimalCELL CULTURE
Per unitML
Dose expressionIC50